Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

MBX Biosciences, Inc.

NASDAQ: MBX · Life Sciences · 5 alerts · CIK 1776111

Share price
$53.12Close, Nov 16
Market cap
$2.64B
Shares outstanding
49.66MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All MBX Biosciences, Inc. filings on SEC EDGAR ↗

4:09 PM ET 10-Q
Financial Results

MBX Biosciences Q3 2026 Results: Net Loss of $62.4M, Loss Widens

MBX Biosciences reported a significant increase in operating expenses for the nine months ended September 30, 2026, with research and development costs rising to $81.5 million. The company's cash and marketable securities position strengthened to approximately $481.6 million following public offerings, while the accumulated deficit grew to $347.5 million. As of November 5, 2026, the company had 49,656,265 shares of common stock outstanding.

Key figure
Net loss $62.4M
4:06 PM ET 8-K
Financial Results

MBX Biosciences Financial Results

MBX Biosciences reported third quarter 2026 financial results, highlighting the initiation of its pivotal Phase 3 oPTimize trial for canvuparatide in hypoparathyroidism. The company ended the quarter with $481.6 million in cash and investments, which is expected to fund operations into 2029.

Term
Q3 2026

“The third quarter marked an important milestone for MBX with the initiation of our pivotal Phase 3 oPTimize trial of once-weekly canvuparatide, a potential best-in-class PTH replacement therapy.”

Steve Hoerter, Chairman and Chief Executive Officer

“With a strong balance sheet and cash runway into 2029, we believe we are well positioned to advance canvuparatide through pivotal development while continuing to invest in our growing obesity portfolio.”

Steve Hoerter, Chairman and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.